MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » KFx defeats Stryker challenge to shoulder anchor patent

KFx defeats Stryker challenge to shoulder anchor patent

By

KFx Medical, StrykerUPDATED Sept. 18, 2019, with additional inter partes win for KFx.

KFx Medical yesterday defeated a challenge by Stryker (NYSE:SYK) to one of its patents covering orthopedic suture anchors when the U.S. Patent Trial & Appeals board declined to initiate an inter partes review.

U.S. patent no. 7,585,311, covering a “System and method for attaching soft tissue to bone,” was already the subject of lengthy battle between Carlsbad, Calif.-based KFx and Arthrex. After suing Arthrex in August 2011, KFx won more than $30 million in damages. A higher court denied Arthrex’s appeals; Arthrex later coughed up $35 million to satisfy the judgment and failed to convince the U.S. Supreme Court review the case. A New Jersey federal judge tossed a lawsuit later brought by Arthrex.

In March, Stryker asked the PTAB for inter partes review, challenging 21 claims of KFx’s ‘311 patent. Yesterday the patent trial board rejected the request, citing the patent surviving its initial prosecution and a subsequent re-examination and the Arthrex lawsuit.

“We find that the asserted art was not a basis for rejection during prosecution or reexamination,” according to the PTAB decision. “The Arthrex litigation and, specifically, the evidence of secondary considerations developed therein, weighs in favor of denying institution.

“Despite knowing of the Arthrex litigation, [Stryker] did not address the secondary considerations evidence in its petition. We have cautioned petitioners in prior proceedings that petitions may be denied if they do not address known evidence of secondary considerations. [Stryker’s] failure to address the known evidence of secondary considerations further weighs in favor of denying institution,” the board decided.

It’s the second win in as many months for KFx over Stryker, which issued an IPR challenge to U.S. patent no. 8,951,287, also covering a “System and method for attaching soft tissue to bone.” In an August 19 decision, the PTAB ruled against initiating the review because Stryker failed to show any evidence that an obviousness challenge could succeed.

In case you missed it

RSS From Medical Design & Outsourcing

  • House committee investigates $70M federal contract for AutoMedx ventilators
    A Congressional committee has launched an investigation into a $70 million White House contract for ventilators that reportedly are inadequate to treat people with COVID-19. The Department of Defense signed a $16.2 million contract in spring 2020 to buy SAVe II ventilators, manufactured by AutoMedx (Addison, Tex.), from the supplier Combat Medical Systems, according to… […]
  • How CGMs can inspire lifestyle changes
    As an early adopter of fitness trackers such as the Fitbit, I’ve long appreciated the power of health data. But my recent experience with a continuous glucose monitor (CGM) has done far more to inspire me to look after my health — even as a nondiabetic. I had heard about the potential of such technology… […]
  • COVID-19 mask factory opens in N.J.
    Hudson Holdings Group today announced it has opened a factory to make up to tens of millions of protective masks a month. The Piscataway, N.J., site will produce more than 200 jobs, according to the company, which is in partnership on the project with the State of New Jersey. “Our ultimate goal is to help,”… […]
  • TE Connectivity posts Street-beating Q1 results, medical sales dip 12%
    TE Connectivity (NYSE:TEL) posted first-quarter results today that beat the consensus on Wall Street. The Schaffhausen, Switzerland-based company reported profits of $381 million, or $1.13 per share, on sales of $3.5 billion for the three months ended Dec. 31, 2020, for a bottom-line gain of 1365.4% sales growth of 11.2% compared with Q1 2020. Adjusted to… […]
  • Could this 3-D printed ‘biomesh’ minimize hernia repair complications?
    Some hernia mesh implants have been associated with adverse post-surgical complications. So researchers at Baylor College of Medicine have developed a 3D-printed biomesh to support and reinforce the damaged abdominal wall and facilitate the healing process. Mesh implants may fail because they promote the adhesion of the intestine, liver or other visceral organs to the… […]
  • Superior Sensor Technology launches versatile differential pressure sensors
    Superior Sensor Technology (Santa Clara, Calif.) today announced the launch of differential pressure sensors for industrial applications that support up to seven selectable pressure ranges in one device. Designed for a wide range of applications, the new ND Series sensors support pressure ranges as low as 62.5 Pa/0.25” H2O to as high as 345 mBar/5… […]
  • BD touts study of antigen test over molecular test for identifying infectious COVID-19 cases
    Becton Dickinson (BD) is touting the results of a small, in-house study of its Veritor Plus antigen test over molecular (PCR) tests to indicate whether an infected person is more likely able to spread SARS-CoV-2. The peer-reviewed study compared antigen and PCR test results to positive results using a viral cell culture test. Viral growth… […]
  • TDK adds pressure sensors for ventilators
    TDK Corporation announced the launch of a new range of differential pressure sensors designed as printed circuit boards for use in medical devices. The sensors are designed for measurement ranges of 16 mbar full-scale (FS), 100 mbar FS and 7 bar FS, with accuracy of up to ±1% FS at temperatures from -20 °C to… […]
  • Pediatric device workshop scheduled for February
    A virtual public meeting on pediatric medical device development is scheduled for Feb. 9-11, 2021. Sponsors include the FDA, AdvaMed, the American Academy of Pediatrics and the Critical Path Institute, a public-private partnership that receives FDA funding. The System of Hospitals for Innovation in Pediatrics – Medical Devices (SHIP-MD) Virtual Workshop will focus on the… […]
  • Pedra wins breakthrough nod for perfusion system
    Singapore-based Pedra Technology announced today that the FDA has granted the company breakthrough device designation for the periprocedural use of its Xauron perfusion system in the treatment of critical limb-threatening ischemia (CLTI). CLTI is a severe form of peripheral artery disease (PAD) that is defined as ischemic rest pain, tissue loss or gangrene (tissue death) that… […]
  • Freudenberg Medical expands U.S. molding operations
    Freudenberg Medical announced that it has expanded injection molding operations at its Baldwin Park, Calif., operation, which is focused on thermoplastics. Freudenberg Medical Baldwin Park has added six injection molding machines including three new Arburg molding machines, a work cell for two-shot molding and a Wittmann Battenfeld micro-molding machine with in-process visual inspection capability. The… […]